Physician profile

Alan Max Jones

Dentist · Grand Junction, CO

NPI 1003369125

$2,581.20

in general payments reported to CMS, 2019-2025

9 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$24.14
Education$15.01

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Patterson Companies, INC. $1,143.92 2022
Voco America INC. $625.00 2019
A-Dec, INC. $464.15 2022
Straumann USA LLC $125.00 2021
Zimmer Biomet Holdings, INC. $105.00 2020
Nobel Biocare USA $54.44 2020-2022
Kerr Corporation $24.54 2022
Zimvie INC. $24.14 2024
Envista Holdings Corporation $15.01 2024 Harmonize

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Alan Max Jones

$2,581.20

in general payments reported 2019-2025

Years
2019-2024
Top company
Patterson Companies, INC.

https://glasscript.com/doctor/1594972/alan-max-jones

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.